This Clinical Knowledge Summaries (CKS) topic supports the National Dementia Strategy and the policy on prescribing antipsychotic drugs for people with dementia.
This CKS topic is based on the guideline on dementia published by the National Institute for Health and Clinical Excellence (NICE), and the NICE Technology Appraisals on donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer’s disease.
This piece also covers guidelines on dementia in people with learning disabilities.
Note: This CKS topic covers the management of dementia in primary care. This CKS topic does not cover initiation of drug treatments that are used in secondary care. It does not cover the management of conditions closely associated with dementia, such as depression, incontinence, and epilepsy. Nor does it cover the management of mild cognitive impairment or presumed pre-dementia.
Taken from the top-level, this topic approaches the subject from the viewpoint of four scenarios. Quote:
“Screening, Diagnosis, and Assessment: discusses the few situations in which routine screening for dementia is recommended, when dementia should be suspected, how to suggest that dementia is a possibility, and what tests should be done before referral for specialist assessment and diagnosis.
Ongoing Management: covers the approach to primary care management of dementia, and the management of cognitive problems, anxiety and depression, and other psychological and behavioural problems.
Managing End-of-Life Problems: briefly covers the principles of palliative care, and reviews the management of some common problems in palliative care.
Supporting Carers: covers how to recognize when carers need support, and how they can be supported”.
Read more: Clinical Knowledge Summaries: Dementia.